id
stringlengths 1
5
| question_id
stringlengths 1
5
| document_id
stringlengths 5
7
| question
stringlengths 55
970
| type
stringclasses 1
value | choices
list | context
stringlengths 0
971
| answer
sequence |
---|---|---|---|---|---|---|---|
9800 | 13533 | 5822856 | Compared to without insoles what was the result of flat insoles or textured insoles on Berg Balance Scale (BBS) and the Timed Up and Go test (TUG)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Outcome measures (BBS and TUG) before and after intervention are shown in Table 2 and Figure 3. A significant improvement was noted after 4 weeks in both G1 and G2 (p<0.0001), but not in CG (p=0.14 and p=0.64 for BBS and TUG, respectively) (Figure 3) | [
"significantly increased"
] |
9801 | 13534 | 5822856 | Compared to textured insoles what was the result of flat insoles on Berg Balance Scale (BBS) and the Timed Up and Go test (TUG)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Outcome measures (BBS and TUG) before and after intervention are shown in Table 2 and Figure 3. A significant improvement was noted after 4 weeks in both G1 and G2 (p<0.0001), but not in CG (p=0.14 and p=0.64 for BBS and TUG, respectively) (Figure 3) | [
"no significant difference"
] |
9802 | 13535 | 5822856 | Compared to textured insoles what was the result of flat insoles on Insole wearing time? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Outcome measures (BBS and TUG) before and after intervention are shown in Table 2 and Figure 3. A significant improvement was noted after 4 weeks in both G1 and G2 (p<0.0001), but not in CG (p=0.14 and p=0.64 for BBS and TUG, respectively) (Figure 3) | [
"no significant difference"
] |
9803 | 13536 | 3695249 | Compared to intravenous 4 mg ondansetron or 0.3 mg ramosetron what was the result of intravenous 75 µg palonosetron on number of patients requested disconnection of the IV-PCA pumps because of intractable nausea and/or vomiting after surgery mostly within 12 h? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Six patients (17.1%) in the ondansetron group, 5 (14.3%) in the ramosetron group, and none (0%) in the palonosetron group (P = 0.041) requested disconnection of the IV-PCA pumps because of intractable nausea and/or vomiting after surgery mostly within 12 h. | [
"significantly decreased"
] |
9804 | 13537 | 3695249 | Compared to intravenous 4 mg ondansetron or 0.3 mg ramosetron what was the result of intravenous 75 µg palonosetron on Pain scores and the total amounts of fentanyl administered via IV-PCA? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Six patients (17.1%) in the ondansetron group, 5 (14.3%) in the ramosetron group, and none (0%) in the palonosetron group (P = 0.041) requested disconnection of the IV-PCA pumps because of intractable nausea and/or vomiting after surgery mostly within 12 h. | [
"no significant difference"
] |
9805 | 13538 | 3695249 | Compared to intravenous 4 mg ondansetron or 0.3 mg ramosetron what was the result of intravenous 75 µg palonosetron on the time to use a rescue emetic? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Six patients (17.1%) in the ondansetron group, 5 (14.3%) in the ramosetron group, and none (0%) in the palonosetron group (P = 0.041) requested disconnection of the IV-PCA pumps because of intractable nausea and/or vomiting after surgery mostly within 12 h. | [
"significantly increased"
] |
9806 | 13540 | 4649576 | Compared to placebo what was the result of vitamin B6 or ginger on the severity of nausea and vomiting? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Comparison of the severity of nausea and vomiting during the treatment days did not show significant difference between the three groups; however, the severity of nausea in placebo group was higher than that of the ginger and vitamin B6 groups during the treatment [Table 3]. | [
"no significant difference"
] |
9807 | 13541 | 4173571 | Compared to single dose of dexamethasone 8 mg with normal saline 2 ml what was the result of single dose of dexamethasone 8 mg with granisetron 1 mg or with ondansetron 4 mg on required rescue antiemetic (RAE)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Only 12% and 20% patients in Group G and O respectively required RAE, as compared to 52% patients in Group D; P = 0.004 | [
"significantly decreased"
] |
9808 | 13542 | 4173571 | Compared to single dose of dexamethasone 8 mg with normal saline 2 ml what was the result of single dose of dexamethasone 8 mg with granisetron 1 mg or with ondansetron 4 mg on A complete response (no PONV or RAE requirement)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Only 12% and 20% patients in Group G and O respectively required RAE, as compared to 52% patients in Group D; P = 0.004 | [
"significantly increased"
] |
9809 | 13545 | 4173571 | Compared to single dose of dexamethasone 8 mg with normal saline 2 ml what was the result of single dose of dexamethasone 8 mg with granisetron 1 mg or with ondansetron 4 mg on Post-operative sedation? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Only 12% and 20% patients in Group G and O respectively required RAE, as compared to 52% patients in Group D; P = 0.004 | [
"no significant difference"
] |
9810 | 13550 | 5860698 | Compared to SBP strategy what was the result of CVD risk strategy on number of CVD events? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Areas under the curve comparing the two treatment strategies throughout the range of possible thresholds for CVD risk and SBP demonstrated that, on average, a greater number of CVD events would be avoided for a given number of persons treated with the CVD risk strategy compared with the SBP strategy (area under the curve 0.71 [95% CI 0.70–0.72] for the CVD risk strategy versus 0.54 [95% CI 0.53–0.55] for the SBP strategy) (Fig 1). | [
"significantly decreased"
] |
9811 | 13551 | 3793517 | Compared to standard eradication therapy what was the result of sequential eradication therapy on Eradication rate? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Six weeks after completion of therapy, H. pylori test on 14C-UBT was negative in 5 (55.6%) of nine patients in the standard and in 4 (57.1%) of 7 patients in the sequential groups. This eradication rate although slightly higher with sequential therapy, it is non-significant (P = 0.949) [Table 1]. | [
"no significant difference"
] |
9812 | 13552 | 3793517 | Compared to standard eradication therapy what was the result of sequential eradication therapy on serum ferritin? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Six weeks after completion of therapy, H. pylori test on 14C-UBT was negative in 5 (55.6%) of nine patients in the standard and in 4 (57.1%) of 7 patients in the sequential groups. This eradication rate although slightly higher with sequential therapy, it is non-significant (P = 0.949) [Table 1]. | [
"no significant difference"
] |
9813 | 13553 | 4687062 | Compared to saline what was the result of bone marrow mononuclear cell (BMMNC) transplantation on Troponin release? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | At 2 days, mean TnI concentration increased in both study groups (mean TnI control group, 3.0 SD 2.0; BMMNC group mean TnI, 3.3 SD 1.9) (Fig 1B). The difference between the groups was not statistically significant (p = 0.71). | [
"no significant difference"
] |
9814 | 13554 | 4687062 | Compared to saline what was the result of bone marrow mononuclear cell (BMMNC) transplantation on The mean absolute change of the global LVEF? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | At 2 days, mean TnI concentration increased in both study groups (mean TnI control group, 3.0 SD 2.0; BMMNC group mean TnI, 3.3 SD 1.9) (Fig 1B). The difference between the groups was not statistically significant (p = 0.71). | [
"no significant difference"
] |
9815 | 13555 | 4687062 | Compared to saline what was the result of bone marrow mononuclear cell (BMMNC) transplantation on cytokines? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | At 2 days, mean TnI concentration increased in both study groups (mean TnI control group, 3.0 SD 2.0; BMMNC group mean TnI, 3.3 SD 1.9) (Fig 1B). The difference between the groups was not statistically significant (p = 0.71). | [
"no significant difference"
] |
9816 | 13560 | 4113172 | Compared to placebo what was the result of lifestyle or metformin on CRP? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | In both ILS and metformin groups, CRP values at EOS were significantly lower than the corresponding placebo group values | [
"significantly decreased"
] |
9817 | 13562 | 4113172 | Compared to placebo what was the result of lifestyle or metformin on tissue plasminogen activator (tPA)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | In both ILS and metformin groups, CRP values at EOS were significantly lower than the corresponding placebo group values | [
"significantly decreased"
] |
9818 | 13570 | 1578575 | Compared to control group-without medication what was the result of tamoxifen/10 mg/day for 14 days on the mean percentage of nuclei stained by Ki-67 (MIB-1) , estrogen receptor (1D5) and progesterone receptor positivity (PgR 636)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | In Group A (control), there was no statistically significant reduction in Ki-67 (MIB-1) (p = 0.627), estrogen receptor (1D5) (p = 0.296) and progesterone receptor positivity (PgR 636) (p = 0.381).
In Group B (tamoxifen 10 mg/day), the mean percentage of nuclei stained by Ki-67 (MIB-1) was 24.69% before and 10.43% after tamoxifen treatment. Mean percentage of nuclei stained by estrogen receptor (1D5) was 59.53% before and 25.99% after tamoxifen treatment. Mean percentage of nuclei stained by progesterone receptor (PgR 636), was 59.34 before and 29.59% after tamoxifen treatment. A statistically significant reduction was found with the three markers (p < 0.001 | [
"significantly decreased"
] |
9819 | 13571 | 4265717 | Compared to undergoing office evaluation what was the result of undergoing office evaluation with a preoperative urodynamic work-up on urogenital distress inventory (UDI) and the incontinence impact questionnaire (IIQ) scores? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | .
At 6 months, a 70% reduction in UDI and IIQ scores was significant in the urodynamic testing group at 86.7% and 73.3%, respectively, compared with only 60.0% and 46.7%, respectively, in the office evaluation only group (p=0.001 and p=0.001 | [
"significantly decreased"
] |
9820 | 13572 | 4265717 | Compared to undergoing office evaluation what was the result of undergoing office evaluation with a preoperative urodynamic work-up on rate of positive provocative stress test? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | .
At 6 months, a 70% reduction in UDI and IIQ scores was significant in the urodynamic testing group at 86.7% and 73.3%, respectively, compared with only 60.0% and 46.7%, respectively, in the office evaluation only group (p=0.001 and p=0.001 | [
"significantly decreased"
] |
9821 | 13573 | 4265717 | Compared to undergoing office evaluation what was the result of undergoing office evaluation with a preoperative urodynamic work-up on treatment outcomes with stratified preoperative values for VLPP and MUCP at both 6 and 12 months? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | .
At 6 months, a 70% reduction in UDI and IIQ scores was significant in the urodynamic testing group at 86.7% and 73.3%, respectively, compared with only 60.0% and 46.7%, respectively, in the office evaluation only group (p=0.001 and p=0.001 | [
"no significant difference"
] |
9822 | 13574 | 3590692 | Compared to usual medical therapy what was the result of combined medical-relaxation therapy on mean scores of depression, anxiety and stress? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | However, after 4 weeks of relaxation, the mean scores of depression, anxiety and stress were significantly different between the two groups (p < 0.05) (Table 1). | [
"significantly decreased"
] |
9823 | 13575 | 3781573 | Compared to insulin-providing (IP) treatment what was the result of insulin-sensitizing (IS) treatment on incidence rate of diabetic peripheral neuropathy (DPN)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Among the 1,075 participants with no DPN at entry, the 4-year cumulative incidence rate of DPN was significantly lower in the IS strategy group (66%) than in the IP strategy group (72%) (P = 0.02) (Fig. 1A). | [
"significantly decreased"
] |
9824 | 13576 | 3781573 | Compared to insulin-providing (IP) treatment what was the result of insulin-sensitizing (IS) treatment on HbA1c? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Among the 1,075 participants with no DPN at entry, the 4-year cumulative incidence rate of DPN was significantly lower in the IS strategy group (66%) than in the IP strategy group (72%) (P = 0.02) (Fig. 1A). | [
"significantly decreased"
] |
9825 | 13577 | 4588430 | Compared to face-to-face consultation what was the result of telephone consultation on mean consultation time? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was a statistically significant lower mean consultation time for telephone consultations across all available follow-up compared to face-to-face consultation. Mean consultation times were 9.8 min (IQR 8 to 12.3) for telephone consultation, and 14.3 min (11.6 to 17.0) for face-to-face consultation with an estimated reduction (95% CI) of 4.3 (2.8 to 5.7) min in consultation times (p < 0.001). | [
"significantly decreased"
] |
9826 | 13578 | 4588430 | Compared to face-to-face consultation what was the result of telephone consultation on NHS costs? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was a statistically significant lower mean consultation time for telephone consultations across all available follow-up compared to face-to-face consultation. Mean consultation times were 9.8 min (IQR 8 to 12.3) for telephone consultation, and 14.3 min (11.6 to 17.0) for face-to-face consultation with an estimated reduction (95% CI) of 4.3 (2.8 to 5.7) min in consultation times (p < 0.001). | [
"significantly decreased"
] |
9827 | 13579 | 4588430 | Compared to face-to-face consultation what was the result of telephone consultation on QOL score? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was a statistically significant lower mean consultation time for telephone consultations across all available follow-up compared to face-to-face consultation. Mean consultation times were 9.8 min (IQR 8 to 12.3) for telephone consultation, and 14.3 min (11.6 to 17.0) for face-to-face consultation with an estimated reduction (95% CI) of 4.3 (2.8 to 5.7) min in consultation times (p < 0.001). | [
"no significant difference"
] |
9828 | 13580 | 4162033 | Compared to atorvastatin (5 mg/d) what was the result of atorvastatin (40 mg/d) on ALT/AST changes? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | there was found no significant relation between different dosages of statin and ALT/AST changes over the study period; and the enzymes fluctuations in all age groups remained in normal range | [
"no significant difference"
] |
9829 | 13583 | 4757000 | Compared to single-incision sling what was the result of transobturator midurethral sling (TOS) on mean daily pad usage? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Preoperatively, mean daily pad usage was calculated as 4.45±0.82 (3–6) in the TOS group, and 4.25±0.78 (3–6) in the single-incision sling group (p=0.495). | [
"no significant difference"
] |
9830 | 13584 | 4757000 | Compared to single-incision sling what was the result of transobturator midurethral sling (TOS) on subjective cure rates? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Preoperatively, mean daily pad usage was calculated as 4.45±0.82 (3–6) in the TOS group, and 4.25±0.78 (3–6) in the single-incision sling group (p=0.495). | [
"no significant difference"
] |
9831 | 13585 | 4757000 | Compared to single-incision sling what was the result of transobturator midurethral sling (TOS) on scores achieved in ICIQ-SF? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Preoperatively, mean daily pad usage was calculated as 4.45±0.82 (3–6) in the TOS group, and 4.25±0.78 (3–6) in the single-incision sling group (p=0.495). | [
"significantly increased"
] |
9832 | 13586 | 4757000 | Compared to single-incision sling what was the result of transobturator midurethral sling (TOS) on scores achieved in I–QOL? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Preoperatively, mean daily pad usage was calculated as 4.45±0.82 (3–6) in the TOS group, and 4.25±0.78 (3–6) in the single-incision sling group (p=0.495). | [
"significantly increased"
] |
9833 | 13587 | 4757000 | Compared to single-incision sling what was the result of transobturator midurethral sling (TOS) on Mean operation time? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Preoperatively, mean daily pad usage was calculated as 4.45±0.82 (3–6) in the TOS group, and 4.25±0.78 (3–6) in the single-incision sling group (p=0.495). | [
"significantly increased"
] |
9834 | 13589 | 5873437 | Compared to standard of care (SOC) only what was the result of 3‐5 days of continuous ELAD treatment plus SOC on Lille score? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Lille score calculation over that period showed 74.7% were responders (Lille < 0.45) in the ELAD group versus 47% in the control group (P < 0.01). | [
"no significant difference"
] |
9835 | 13590 | 5873437 | Compared to standard of care (SOC) only what was the result of 3‐5 days of continuous ELAD treatment plus SOC on IL1Ra levels? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Lille score calculation over that period showed 74.7% were responders (Lille < 0.45) in the ELAD group versus 47% in the control group (P < 0.01). | [
"significantly increased"
] |
9836 | 13591 | 5873437 | Compared to standard of care (SOC) only what was the result of 3‐5 days of continuous ELAD treatment plus SOC on positive postdischarge PEth? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Lille score calculation over that period showed 74.7% were responders (Lille < 0.45) in the ELAD group versus 47% in the control group (P < 0.01). | [
"significantly decreased"
] |
9837 | 13592 | 5440059 | Compared to usual care (UC) only what was the result of usual care plus management by health professionals, with need-based referrals on urinary incontinence (UI) ? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | .
Using a one-sided Fisher’s exact test, no statistically significant differences between groups for UI at midpoint (.125, CI = [0.00, 0.360], p = .247) or final assessment (.25, CI = [0.00, 0.515], p = .068) were found | [
"no significant difference"
] |
9838 | 13593 | 5440059 | Compared to usual care (UC) only what was the result of usual care plus management by health professionals, with need-based referrals on presence of nocturia? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | .
Using a one-sided Fisher’s exact test, no statistically significant differences between groups for UI at midpoint (.125, CI = [0.00, 0.360], p = .247) or final assessment (.25, CI = [0.00, 0.515], p = .068) were found | [
"no significant difference"
] |
9839 | 13594 | 3695250 | Compared to saline infusion following bolus of saline or ketamine infusion of 1 µg/kg/min following bolus 0.5 mg/kg what was the result of ketamine infusion of 2 µg/kg/min following bolus 0.5 mg/kg on The total amount of fentanyl consumption during the 48 h after surgery? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The total amount of fentanyl consumption was significantly lower in the K2 group (474 µg) compared to the control group (826 µg) and the K1 group (756 µg) during the 48 h after surgery (P < 0.05) (Table 2). | [
"significantly decreased"
] |
9840 | 13595 | 3695250 | Compared to saline infusion following bolus of saline or ketamine infusion of 1 µg/kg/min following bolus 0.5 mg/kg what was the result of ketamine infusion of 2 µg/kg/min following bolus 0.5 mg/kg on VAS scores for pain at rest or with movement at 1, 6, 24 and 48 h postoperatively? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The total amount of fentanyl consumption was significantly lower in the K2 group (474 µg) compared to the control group (826 µg) and the K1 group (756 µg) during the 48 h after surgery (P < 0.05) (Table 2). | [
"no significant difference"
] |
9841 | 13596 | 3695250 | Compared to saline infusion following bolus of saline or ketamine infusion of 1 µg/kg/min following bolus 0.5 mg/kg what was the result of ketamine infusion of 2 µg/kg/min following bolus 0.5 mg/kg on The patient satisfaction rate? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The total amount of fentanyl consumption was significantly lower in the K2 group (474 µg) compared to the control group (826 µg) and the K1 group (756 µg) during the 48 h after surgery (P < 0.05) (Table 2). | [
"no significant difference"
] |
9842 | 13597 | 3695250 | Compared to saline infusion following bolus of saline or ketamine infusion of 1 µg/kg/min following bolus 0.5 mg/kg what was the result of ketamine infusion of 2 µg/kg/min following bolus 0.5 mg/kg on The incidence of adverse events? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The total amount of fentanyl consumption was significantly lower in the K2 group (474 µg) compared to the control group (826 µg) and the K1 group (756 µg) during the 48 h after surgery (P < 0.05) (Table 2). | [
"no significant difference"
] |
9843 | 13601 | 2797956 | Compared to 1-day control phase with intraperitoneal open-loop insulin delivery what was the result of Two-day closed-loop therapy (except for a 15-min premeal manual bolus) on percentage of time between 4.4 and 6.6 mmol/l? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | A significantly higher percentage of time was spent between 4.4 and 6.6 mmol/l during closed-loop versus control phases (39.1 ± 4.5 vs. 27.7 ± 6.2%, P = 0.05), | [
"significantly increased"
] |
9844 | 13602 | 2797956 | Compared to 1-day control phase with intraperitoneal open-loop insulin delivery what was the result of Two-day closed-loop therapy (except for a 15-min premeal manual bolus) on plasma insulin peak levels? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | A significantly higher percentage of time was spent between 4.4 and 6.6 mmol/l during closed-loop versus control phases (39.1 ± 4.5 vs. 27.7 ± 6.2%, P = 0.05), | [
"significantly decreased"
] |
9845 | 13604 | 31579 | Compared to atrial natriuretic peptide (ANP) infusion (10 ng/kg/min for 1 hour) what was the result of inhalation of nitric oxide (NO) (20 ppm for 1 hour) on mean pulmonary artery pressure, pulmonary vascular resistance index and central venous pressure ? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Despite an approximate 50% increase in mixed venous ANP plasma concentration (from 86 ± 21 to 123 ± 33 ng/l, P < 0.05) during ANP infusion, there were no changes in mean pulmonary artery pressure, pulmonary vascular resistance index, extravascular lung water index, or in pulmonary gas exchange. NO inhalation, in contrast, lowered mean pulmonary artery pressure (from 26 ± 1.9 to 23.9 ± 1.7 mmHg, P < 0.01), pulmonary vascular resistance index (from 314 ± 37 to 273 ± 32 dynes/cm5/m2, P < 0.05) and central venous pressure (from 8.2 ± 1.2 to 7.3 ± 1.1 mmHg, P < 0.02). | [
"significantly decreased"
] |
9846 | 13607 | 3511174 | Compared to BoNT-A plus eight weeks resistance training (BT) what was the result of Botulinum Toxin-A (BoNT-A) treatment (B) on improvements in AHA and Melbourne? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Both groups had very small improvements in AHA and Melbourne two months after BoNT-A injections, without differences between groups. | [
"no significant difference"
] |
9847 | 13608 | 3511174 | Compared to BoNT-A plus eight weeks resistance training (BT) what was the result of Botulinum Toxin-A (BoNT-A) treatment (B) on The muscle tone? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Both groups had very small improvements in AHA and Melbourne two months after BoNT-A injections, without differences between groups. | [
"no significant difference"
] |
9848 | 13609 | 3511174 | Compared to BoNT-A plus eight weeks resistance training (BT) what was the result of Botulinum Toxin-A (BoNT-A) treatment (B) on Forearm supination resistance? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Both groups had very small improvements in AHA and Melbourne two months after BoNT-A injections, without differences between groups. | [
"significantly decreased"
] |
9849 | 13610 | 3511174 | Compared to BoNT-A plus eight weeks resistance training (BT) what was the result of Botulinum Toxin-A (BoNT-A) treatment (B) on muscle strength in injected muscles nd non-injected muscles? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Both groups had very small improvements in AHA and Melbourne two months after BoNT-A injections, without differences between groups. | [
"no significant difference"
] |
9850 | 13611 | 4358417 | Compared to placebo what was the result of 100 mg of rosehip extract on body weight and BMI? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | the decreases in the body weight and BMI were significantly larger at W12 in the rosehip group than in the placebo group | [
"significantly decreased"
] |
9851 | 13612 | 4358417 | Compared to placebo what was the result of 100 mg of rosehip extract on the abdominal total fat area? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | the decreases in the body weight and BMI were significantly larger at W12 in the rosehip group than in the placebo group | [
"significantly decreased"
] |
9852 | 13617 | 5561588 | Compared to endotracheal intubation after onset at the trapezius muscle (B) what was the result of endotracheal intubation after onset of the neuromuscular block at the adductor pollicis muscle (A) on time to maximum block? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Following injection of rocuronium, maximum block was recorded slightly later at the adductor pollicis muscle compared to the trapezius muscle: 2.8 ± 1.1 versus 2.5 ± 1.1 min, respectively, (mean ± SD; P = 0.006). | [
"significantly increased"
] |
9853 | 13621 | 1208905 | Compared to receive a single session of placebo acupuncture what was the result of receive a single session of true acupuncture on score at follow-up? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | For all analyses, patients receiving true acupuncture reported slightly higher scores at follow-up, approximately equivalent to 10% of baseline. Patients in both groups improved, but no important differences between groups emerged. | [
"no significant difference"
] |
9854 | 13622 | 1208905 | Compared to receive a single session of placebo acupuncture what was the result of receive a single session of true acupuncture on Breathlessness? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | For all analyses, patients receiving true acupuncture reported slightly higher scores at follow-up, approximately equivalent to 10% of baseline. Patients in both groups improved, but no important differences between groups emerged. | [
"no significant difference"
] |
9855 | 13623 | 3931289 | Compared to placebo what was the result of esomeprazole 40 mg twice daily on time to first pulmonary exacerbation? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no significant difference in time to first pulmonary exacerbation between the esomeprazole and placebo groups (log rank test p = 0.3169) (Figure 2). | [
"no significant difference"
] |
9856 | 13624 | 3931289 | Compared to placebo what was the result of esomeprazole 40 mg twice daily on exacerbation rate? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no significant difference in time to first pulmonary exacerbation between the esomeprazole and placebo groups (log rank test p = 0.3169) (Figure 2). | [
"no significant difference"
] |
9857 | 13625 | 3931289 | Compared to placebo what was the result of esomeprazole 40 mg twice daily on change in FEV1 percent or FVC percent? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no significant difference in time to first pulmonary exacerbation between the esomeprazole and placebo groups (log rank test p = 0.3169) (Figure 2). | [
"no significant difference"
] |
9858 | 13626 | 3931289 | Compared to placebo what was the result of esomeprazole 40 mg twice daily on GSAS and CFQ-R score? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no significant difference in time to first pulmonary exacerbation between the esomeprazole and placebo groups (log rank test p = 0.3169) (Figure 2). | [
"no significant difference"
] |
9859 | 13632 | 3664374 | Compared to placebo what was the result of adalimumab on percentage of nr-axSpA patients achieved the primary endpoint of ASAS40 response at week 12? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | A significantly greater percentage of nr-axSpA patients treated with adalimumab achieved the primary endpoint of ASAS40 response at week 12 (33/91, 36%) compared with patients treated with placebo (14/94, 15%; p<0.001, NRI; figure 2A). | [
"significantly increased"
] |
9860 | 13633 | 3664374 | Compared to placebo what was the result of adalimumab on number of patients who had BASFI <2 at week 12? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | A significantly greater percentage of nr-axSpA patients treated with adalimumab achieved the primary endpoint of ASAS40 response at week 12 (33/91, 36%) compared with patients treated with placebo (14/94, 15%; p<0.001, NRI; figure 2A). | [
"significantly increased"
] |
9861 | 13637 | 5827042 | Compared to dexmedetomidine-fentanyl what was the result of the combination of fentanyl-midazolam on treatment failure? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Out of the 9 patients who experienced treatment failure, 8 (88.90%) patients were in dexmedetomidine group and 1 (11.10%) was in the midazolam group (p = 0.029). | [
"significantly decreased"
] |
9862 | 13638 | 5827042 | Compared to dexmedetomidine-fentanyl what was the result of the combination of fentanyl-midazolam on time to recovery? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Out of the 9 patients who experienced treatment failure, 8 (88.90%) patients were in dexmedetomidine group and 1 (11.10%) was in the midazolam group (p = 0.029). | [
"significantly decreased"
] |
9863 | 13639 | 3606612 | Compared to IV iron sucrose 200 mg monthly what was the result of 11 mg of Heme Iron Polypeptide (HIP) orally 3 times per day on hemoglobin? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no difference in the Hb in the HIP group was 117 g/L and 113 g/L in the IV sucrose group at 6 months (p = 0.37; Table 3). | [
"no significant difference"
] |
9864 | 13640 | 3606612 | Compared to IV iron sucrose 200 mg monthly what was the result of 11 mg of Heme Iron Polypeptide (HIP) orally 3 times per day on TSAT? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no difference in the Hb in the HIP group was 117 g/L and 113 g/L in the IV sucrose group at 6 months (p = 0.37; Table 3). | [
"no significant difference"
] |
9865 | 13641 | 3606612 | Compared to IV iron sucrose 200 mg monthly what was the result of 11 mg of Heme Iron Polypeptide (HIP) orally 3 times per day on serum ferritin? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no difference in the Hb in the HIP group was 117 g/L and 113 g/L in the IV sucrose group at 6 months (p = 0.37; Table 3). | [
"significantly decreased"
] |
9866 | 13642 | 3606612 | Compared to IV iron sucrose 200 mg monthly what was the result of 11 mg of Heme Iron Polypeptide (HIP) orally 3 times per day on adverse effects? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There was no difference in the Hb in the HIP group was 117 g/L and 113 g/L in the IV sucrose group at 6 months (p = 0.37; Table 3). | [
"no significant difference"
] |
9867 | 13643 | 5745479 | Compared to placebo what was the result of amoxicillin on proportion of any AE? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | For the whole cohort, at the end of week one, a significantly higher proportion of any AE (diarrhoea or nausea or rash) was reported in the amoxicillin group compared to placebo (OR = 1.31, 95% CI 1.05–1.64) (Table 1). | [
"significantly increased"
] |
9868 | 13644 | 5745479 | Compared to placebo what was the result of amoxicillin on diarrhoea? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | For the whole cohort, at the end of week one, a significantly higher proportion of any AE (diarrhoea or nausea or rash) was reported in the amoxicillin group compared to placebo (OR = 1.31, 95% CI 1.05–1.64) (Table 1). | [
"significantly increased"
] |
9869 | 13645 | 5745479 | Compared to placebo what was the result of amoxicillin on Nausea? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | For the whole cohort, at the end of week one, a significantly higher proportion of any AE (diarrhoea or nausea or rash) was reported in the amoxicillin group compared to placebo (OR = 1.31, 95% CI 1.05–1.64) (Table 1). | [
"no significant difference"
] |
9870 | 13646 | 5745479 | Compared to placebo what was the result of amoxicillin on rash in males? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | For the whole cohort, at the end of week one, a significantly higher proportion of any AE (diarrhoea or nausea or rash) was reported in the amoxicillin group compared to placebo (OR = 1.31, 95% CI 1.05–1.64) (Table 1). | [
"significantly increased"
] |
9871 | 13647 | 4753023 | Compared to placebo what was the result of one ferrous sulfate tablet containing 50 mg of elemental iron daily on The mean Hb concentration? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The mean Hb concentration was 12.05 ± 0.9 in the experimental and 11.94 ± 0.6 in the placebo group; this different was significant (P = 0.03) | [
"significantly increased"
] |
9872 | 13648 | 4753023 | Compared to placebo what was the result of one ferrous sulfate tablet containing 50 mg of elemental iron daily on the mean of birth weight? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The mean Hb concentration was 12.05 ± 0.9 in the experimental and 11.94 ± 0.6 in the placebo group; this different was significant (P = 0.03) | [
"no significant difference"
] |
9873 | 13649 | 4753023 | Compared to placebo what was the result of one ferrous sulfate tablet containing 50 mg of elemental iron daily on ferritin? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The mean Hb concentration was 12.05 ± 0.9 in the experimental and 11.94 ± 0.6 in the placebo group; this different was significant (P = 0.03) | [
"significantly increased"
] |
9874 | 13650 | 3714385 | Compared to remifentanil at infusion rates of 0.5 μg·kg-1·min-1 (H) what was the result of remifentanil at infusion rates of 0.1 μg·kg-1·min-1 (L) on HOMA-IR before induction of anaesthesia, 60 min after the start of surgery, and at the start of skin closure? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | HOMA-IR varied within normal limits before induction of anaesthesia, 60 min after the start of surgery, and at the start of skin closure, with no significant differences between the 2 groups. | [
"no significant difference"
] |
9875 | 13651 | 3714385 | Compared to remifentanil at infusion rates of 0.5 μg·kg-1·min-1 (H) what was the result of remifentanil at infusion rates of 0.1 μg·kg-1·min-1 (L) on HOMA-β values at 60 min after the start of surgery and skin closure? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | HOMA-IR varied within normal limits before induction of anaesthesia, 60 min after the start of surgery, and at the start of skin closure, with no significant differences between the 2 groups. | [
"no significant difference"
] |
9876 | 13652 | 3714385 | Compared to remifentanil at infusion rates of 0.5 μg·kg-1·min-1 (H) what was the result of remifentanil at infusion rates of 0.1 μg·kg-1·min-1 (L) on 3-MH/Cr values? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | HOMA-IR varied within normal limits before induction of anaesthesia, 60 min after the start of surgery, and at the start of skin closure, with no significant differences between the 2 groups. | [
"no significant difference"
] |
9877 | 13653 | 3751503 | Compared to BioCleanse-sterilized allografts what was the result of aseptic bone-patellar tendon-bone (BTB) allografts on IKDC or KT-1000 results? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | . IKDC or KT-1000 results were not significantly different between groups at any time point. | [
"no significant difference"
] |
9878 | 13654 | 3751503 | Compared to BioCleanse-sterilized allografts what was the result of aseptic bone-patellar tendon-bone (BTB) allografts on Active flexion ROM? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | . IKDC or KT-1000 results were not significantly different between groups at any time point. | [
"no significant difference"
] |
9879 | 13655 | 3751503 | Compared to BioCleanse-sterilized allografts what was the result of aseptic bone-patellar tendon-bone (BTB) allografts on Active extension ROM? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | . IKDC or KT-1000 results were not significantly different between groups at any time point. | [
"no significant difference"
] |
9880 | 13656 | 5319516 | Compared to atorvastatin 20 mg (A20 group) or atorvastatin 40 mg (A40 group) what was the result of zhibitai 480 mg + atorvastatin 10 mg (ZA10 group) on triglycerides? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no differences in TG levels among the 3 groups at 8 weeks (P > 0.05) (Table 2) | [
"no significant difference"
] |
9881 | 13657 | 5319516 | Compared to atorvastatin 20 mg (A20 group) or atorvastatin 40 mg (A40 group) what was the result of zhibitai 480 mg + atorvastatin 10 mg (ZA10 group) on cardiotrophin-1 (CT-1) and high sensitivity-C reactive protein (hs-CRP)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no differences in TG levels among the 3 groups at 8 weeks (P > 0.05) (Table 2) | [
"no significant difference"
] |
9882 | 13658 | 5319516 | Compared to atorvastatin 20 mg (A20 group) or atorvastatin 40 mg (A40 group) what was the result of zhibitai 480 mg + atorvastatin 10 mg (ZA10 group) on creatine kinase? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | There were no differences in TG levels among the 3 groups at 8 weeks (P > 0.05) (Table 2) | [
"no significant difference"
] |
9883 | 13662 | 5516151 | Compared to cyclosporine what was the result of belatacept (more intense [MI] or less intense [LI]) on time to death or graft loss? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Hazard ratios (HRs) comparing time to death or graft loss were 0.915 (95% confidence interval [CI] 0.625–1.339; p = 0.65) for belatacept MI versus cyclosporine and 0.927 (95% CI 0.634–1.356; p = 0.70) for belatacept LI versus cyclosporine. | [
"no significant difference"
] |
9884 | 13663 | 5516151 | Compared to cyclosporine what was the result of belatacept (more intense [MI] or less intense [LI]) on Mean estimated GFR (eGFR)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Hazard ratios (HRs) comparing time to death or graft loss were 0.915 (95% confidence interval [CI] 0.625–1.339; p = 0.65) for belatacept MI versus cyclosporine and 0.927 (95% CI 0.634–1.356; p = 0.70) for belatacept LI versus cyclosporine. | [
"significantly increased"
] |
9885 | 13664 | 5516151 | Compared to cyclosporine what was the result of belatacept (more intense [MI] or less intense [LI]) on Acute rejection rates and safety profiles? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Hazard ratios (HRs) comparing time to death or graft loss were 0.915 (95% confidence interval [CI] 0.625–1.339; p = 0.65) for belatacept MI versus cyclosporine and 0.927 (95% CI 0.634–1.356; p = 0.70) for belatacept LI versus cyclosporine. | [
"no significant difference"
] |
9886 | 13669 | 3258705 | Compared to the control group received vaginal administration of progesterone supplementation alone starting on the day after oocyte retrieval and continued until the tenth week if the chemical pregnancy test was positive what was the result of oestradiol group, 2 mg of oestradiol valerate was initiated orally with progesterone on The mean duration of infertility? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The mean duration of infertility was 5.98 ±0.55 years in the control group and 7.81 ±1.37 years in the oestradiol group, but this difference was not statistically significant (P > 0.05). | [
"no significant difference"
] |
9887 | 13670 | 3258705 | Compared to the control group received vaginal administration of progesterone supplementation alone starting on the day after oocyte retrieval and continued until the tenth week if the chemical pregnancy test was positive what was the result of oestradiol group, 2 mg of oestradiol valerate was initiated orally with progesterone on luteinizing hormone (LH)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The mean duration of infertility was 5.98 ±0.55 years in the control group and 7.81 ±1.37 years in the oestradiol group, but this difference was not statistically significant (P > 0.05). | [
"no significant difference"
] |
9888 | 13671 | 3258705 | Compared to the control group received vaginal administration of progesterone supplementation alone starting on the day after oocyte retrieval and continued until the tenth week if the chemical pregnancy test was positive what was the result of oestradiol group, 2 mg of oestradiol valerate was initiated orally with progesterone on serum level of progesterone and oestradiol? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The mean duration of infertility was 5.98 ±0.55 years in the control group and 7.81 ±1.37 years in the oestradiol group, but this difference was not statistically significant (P > 0.05). | [
"no significant difference"
] |
9889 | 13672 | 3258705 | Compared to the control group received vaginal administration of progesterone supplementation alone starting on the day after oocyte retrieval and continued until the tenth week if the chemical pregnancy test was positive what was the result of oestradiol group, 2 mg of oestradiol valerate was initiated orally with progesterone on The mean number of retrieved oocytes, number of transferred embryos, and chemical and clinical pregnancy rate? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The mean duration of infertility was 5.98 ±0.55 years in the control group and 7.81 ±1.37 years in the oestradiol group, but this difference was not statistically significant (P > 0.05). | [
"no significant difference"
] |
9890 | 13673 | 5827507 | Compared to 1-5% potassium nitrate (KNO3) what was the result of combined 5% KNO3 and the diode laser on Dentinal hypersensitivity (DH)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | A significant reduction in DH was observed for Group 3 (GaAlA laser diode and 5% KNO3) and Group 2 (GaAlA laser diode) than Group 1 (5% KNO3). | [
"significantly decreased"
] |
9891 | 13674 | 5827507 | Compared to 1-5% potassium nitrate (KNO3) what was the result of gallium-aluminum-arsenide diode laser on Dentinal hypersensitivity (DH)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | A significant reduction in DH was observed for Group 3 (GaAlA laser diode and 5% KNO3) and Group 2 (GaAlA laser diode) than Group 1 (5% KNO3). | [
"significantly decreased"
] |
9892 | 13675 | 4588672 | Compared to no intervention what was the result of constraint-induced aphasia therapy (CIAT) on mini-Communicative Abilities Log (mini-CAL) score at 12 weeks? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Patients who received CIAT scored higher on the mini-CAL at 12 weeks after intervention compared to the control group (Mean 31 vs. 23; difference=8, 95% CI 1.3 to 13.5, p=0.019) | [
"significantly increased"
] |
9893 | 13676 | 4588672 | Compared to no intervention what was the result of constraint-induced aphasia therapy (CIAT) on the Semantic Fluency Test (SFT) score? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | Patients who received CIAT scored higher on the mini-CAL at 12 weeks after intervention compared to the control group (Mean 31 vs. 23; difference=8, 95% CI 1.3 to 13.5, p=0.019) | [
"no significant difference"
] |
9894 | 13677 | 4951149 | Compared to healthy-carbohydrate diet (HCD) what was the result of low-fibre Western-style diet (WSD) on faecal consistency? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The faecal consistency differed significantly (P = 0.02) between the two interventions. Six subjects reported constipation during the WSD compared with one subject during the HCD. | [
"significantly increased"
] |
9895 | 13678 | 4951149 | Compared to low-fibre Western-style diet (WSD) what was the result of healthy-carbohydrate diet (HCD) on number of observed species (alpha-diversity) in the stools ? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The faecal consistency differed significantly (P = 0.02) between the two interventions. Six subjects reported constipation during the WSD compared with one subject during the HCD. | [
"significantly decreased"
] |
9896 | 13679 | 3560577 | Compared to pantoprazole 40 mg intravenously what was the result of Lansoprazole 30 mg intravenously on The mean time for pH >4 and pH >6? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The mean time for pH >4 and pH >6 with lansoprazole was shorter than with pantoprazole on day 1, but the difference was not statistically significant (109.61±32.15 min vs. 153.42±29.36 min, P=0.3304 for pH 4; and 211.93±39.18 min vs. 288.43±35.79 min, P=0.1706 for pH 6). | [
"no significant difference"
] |
9897 | 13680 | 3681405 | Compared to surgery-alone arm what was the result of preoperative chemotherapy plus surgery on The median survival time (MST) for patients with non-small cell lung cancer (NSCLC)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The median survival time (MST) was 45.42 months in the preoperative chemotherapy arm and 57.59 months in the surgery-alone arm (log-rank P = 0.016), with a HR of death of 1.67 (95% CI, 1.43–1.96 | [
"significantly decreased"
] |
9898 | 13681 | 3681405 | Compared to surgery-alone arm what was the result of preoperative chemotherapy plus surgery on The MST of stage II non-small cell lung cancer (NSCLC)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The median survival time (MST) was 45.42 months in the preoperative chemotherapy arm and 57.59 months in the surgery-alone arm (log-rank P = 0.016), with a HR of death of 1.67 (95% CI, 1.43–1.96 | [
"significantly decreased"
] |
9899 | 13682 | 3681405 | Compared to surgery-alone arm what was the result of preoperative chemotherapy plus surgery on survival rates of stage I and stage IIIA non-small cell lung cancer (NSCLC)? | multiple_choice | [
"significantly increased",
"no significant difference",
"significantly decreased"
] | The median survival time (MST) was 45.42 months in the preoperative chemotherapy arm and 57.59 months in the surgery-alone arm (log-rank P = 0.016), with a HR of death of 1.67 (95% CI, 1.43–1.96 | [
"no significant difference"
] |